Zoetis Inc.
ZTSNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for ZTS. That does not mean none is planned.
Get an email about ZTS's next catalysts
Track Zoetis (ZTS) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 1 past
No catalysts found.
Market Overview
Stock performance and key metrics
Zoetis Inc. (/zΕ-EH-tis/) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index.
WebsiteNo drugs found in this phase.
Frequently asked questions
When is Zoetis Inc.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for Zoetis Inc. (ZTS) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track ZTS biotech catalysts?β
Add ZTS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Zoetis Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.